The abstract is read at the publisher; the summary is JClub's.
An MPRA screen in CD34+ cells identified 87 regulatory noncoding variants across 32 CHIP-associated loci, including an MSI2 enhancer variant linked to clonal expansion of Tet2-deficient HSPCs.
- Why it matters: CHIP risk loci from GWAS lack clear mechanisms, and enhancer-level effects in HSPCs could explain how inherited noncoding variation shapes clonal hematopoiesis.
- What they did: The study tested 1,374 noncoding variants from 51 CHIP-associated loci using MPRA in CD34+ MUTZ-3 cells, then validated enhancer activity for variants regulating NKD2, FLT3, and MSI2 in primary human HSPCs.
- The result: Modeling the CHIP risk allele increased MSI2 expression and promoted clonal expansion of Tet2-deficient HSPCs, providing a mechanistic link between germline enhancer variation and CHIP progression.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.